Our liver cancer researchers and clinicians work together to translate discoveries from the lab into new options for patients. Many also care for patients, allowing them to quickly move promising findings into clinical trials.
When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy.
Fred Hutch and UW Medicine researchers are advancing how liver cancer is detected and treated by studying the genetic and molecular drivers of the disease. Our teams develop new models of liver cancer, identify biomarkers for earlier diagnosis, and test innovative therapies through clinical trials.
This research focuses on improving survival while reducing treatment‑related side effects for people with liver cancer.
Liver Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Our Areas of Research of Liver Cancer
Our researchers study the molecular mechanisms behind how liver tumors form and the factors that affect how liver cancer develops. They aim to use these findings to advance early detection and diagnosis. Our scientists also study the factors that affect whether a particular treatment works for a given patient.
Our Liver Cancer Researchers and Faculty
Our liver cancer researchers and clinicians work together to prevent, diagnose and treat liver cancer. Many also care for patients, helping move research discoveries quickly into clinical trials and new treatment options.
See below for our researchers and faculty or view our liver cancer care team providers.
